Additionally, it was shown that mice lacking IRF5 in myeloid cells demonstrated reduced hepatic fibrosis in the acute CCl4 toxic model and in the nonalcoholic steatosis model (NASH). This evidence concerns the gene IRF5 and Hepatic fibrosis.